2024 Q1 Form 10-K Financial Statement

#000149315224009954 Filed on March 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023 Q2
Revenue $11.27M $6.952M $2.186M
YoY Change 72.62% 41.7% -158.86%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.146M $2.441M $2.332M
YoY Change 62.78% 4.09% 2.78%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $317.0K $200.0K
YoY Change 19.17%
% of Gross Profit
Operating Expenses $14.58M $7.162M $5.109M
YoY Change 181.53% 50.05% 7.72%
Operating Profit -$5.932M -$6.206M
YoY Change 43.67%
Interest Expense $225.0K -$1.698M
YoY Change -91.6% -44.69%
% of Operating Profit
Other Income/Expense, Net $1.795M -$92.00K
YoY Change 5509.38%
Pretax Income -$4.137M -$210.0K -$2.923M
YoY Change -406.44% -257.89% -46.64%
Income Tax $116.0K -$14.00K
% Of Pretax Income
Net Earnings -$4.445M -$657.0K -$2.923M
YoY Change -429.26% 109.24% -46.64%
Net Earnings / Revenue -39.45% -9.45% -133.71%
Basic Earnings Per Share -$0.27 -$0.54
Diluted Earnings Per Share -$0.27 -$0.06 -$0.35
COMMON SHARES
Basic Shares Outstanding 28.37M shares 10.56M shares 9.439M shares
Diluted Shares Outstanding 16.74K shares 9.705M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $7.209M $2.396M $2.962M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $4.446M $4.079M
Prepaid Expenses
Receivables $6.285M $6.477M
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $4.286M $12.22M $48.00K
YoY Change 8142.31% 21721.43% -99.93%
Goodwill $881.0K $903.0K
YoY Change
Intangibles
YoY Change
Long-Term Investments $23.95M $23.53M $25.78M
YoY Change -12.84% -8.36% 135.97%
Other Assets $21.57M $10.61M
YoY Change 132.72% 44.68%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $110.3M $65.74M $48.57M
YoY Change 120.54% 32.87% 30.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $206.0K $508.0K
YoY Change -71.51% 29.59%
Accrued Expenses $48.00K
YoY Change -99.93%
Deferred Revenue
YoY Change
Short-Term Debt $4.592M $4.732M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $206.0K $556.0K
YoY Change -71.51% 41.84%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $93.00K $546.0K $116.0K
YoY Change -51.05% 142.67% -0.85%
Total Long-Term Liabilities $93.00K $546.0K $116.0K
YoY Change -51.05% 142.67% -0.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $206.0K $556.0K
Total Long-Term Liabilities $93.00K $546.0K $116.0K
Total Liabilities $43.68M $23.24M $11.56M
YoY Change 290.06% 90.84% 20.91%
SHAREHOLDERS EQUITY
Retained Earnings -$2.161M -$33.15M -$37.67M
YoY Change -93.7% -5.56% -15.53%
Common Stock $28.00K $10.00K $10.00K
YoY Change 211.11% 11.11% 11.11%
Preferred Stock
YoY Change
Treasury Stock (at cost) $18.59M
YoY Change
Treasury Stock Shares
Shareholders Equity $64.80M $42.49M $37.01M
YoY Change
Total Liabilities & Shareholders Equity $110.3M $65.74M $48.57M
YoY Change 120.54% 32.87% 30.3%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023 Q2
OPERATING ACTIVITIES
Net Income -$4.445M -$657.0K -$2.923M
YoY Change -429.26% 109.24% -46.64%
Depreciation, Depletion And Amortization $317.0K $200.0K
YoY Change 19.17%
Cash From Operating Activities -$1.030M -$2.147M
YoY Change -237.33% 5863.89%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions $1.800M
YoY Change
Other Investing Activities $44.00K
YoY Change -95.95%
Cash From Investing Activities $2.234M $44.00K
YoY Change 143.62% -95.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$634.0K 761.0K
YoY Change 69.97% -77.2%
NET CHANGE
Cash From Operating Activities -$1.030M -2.147M
Cash From Investing Activities $2.234M 44.00K
Cash From Financing Activities -$634.0K 761.0K
Net Change In Cash $565.0K -1.342M
YoY Change -56.34% -130.99%
FREE CASH FLOW
Cash From Operating Activities -$1.030M -$2.147M
Capital Expenditures $0.00
Free Cash Flow -$2.147M
YoY Change -10835.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001591890
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022 FGF Increase In Investment Without Readily Determinable Fair Value
IncreaseInInvestmentWithoutReadilyDeterminableFairValue
usd
CY2022 FGF Increase In Fair Value Of Convertible Note
IncreaseInFairValueOfConvertibleNote
usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2022 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
usd
CY2022 FGF Carrying Value Of Limited Liability Company Interests Received In Connection With Fg Special Situations Fund Unwind
CarryingValueOfLimitedLiabilityCompanyInterestsReceivedInConnectionWithFgSpecialSituationsFundUnwind
usd
CY2022 FGF Equity Securities In Oppfi Received In Connection With Fg Special Situations Fund Unwind
EquitySecuritiesInOppfiReceivedInConnectionWithFgSpecialSituationsFundUnwind
usd
CY2022 FGF Equity Securities In Icoreconnect Inc Received In Connection With Conversion Of Bridge Loan
EquitySecuritiesInIcoreconnectIncReceivedInConnectionWithConversionOfBridgeLoan
usd
CY2023 us-gaap Debt Securities Trading Unrealized Loss
DebtSecuritiesTradingUnrealizedLoss
usd
CY2022 us-gaap Debt Securities Trading Unrealized Gain
DebtSecuritiesTradingUnrealizedGain
usd
CY2022Q4 us-gaap Other Notes Payable
OtherNotesPayable
usd
CY2023 FGF Contributions In Investments Without Readily Determinable Fair Value
ContributionsInInvestmentsWithoutReadilyDeterminableFairValue
usd
CY2022 FGF Increase Due To Change In Observable Price
IncreaseDueToChangeInObservablePrice
usd
CY2023 FGF Income Tax Expense Benefit From Continuing And Discontinued Operations
IncomeTaxExpenseBenefitFromContinuingAndDiscontinuedOperations
usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2022 FGF Income Tax Expense Benefit From Continuing And Discontinued Operations
IncomeTaxExpenseBenefitFromContinuingAndDiscontinuedOperations
usd
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-36366
CY2023 dei Entity Registrant Name
EntityRegistrantName
Fundamental Global Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-1119100
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
108 Gateway Blvd
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 204
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Mooresville
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
28117
CY2023 dei City Area Code
CityAreaCode
(704)
CY2023 dei Local Phone Number
LocalPhoneNumber
323-6851
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
8213211 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28369066 shares
CY2023 dei Auditor Firm
AuditorFirmId
243
CY2023 dei Auditor Name
AuditorName
BDO USA, P.C.
CY2023 dei Auditor Location
AuditorLocation
Grand Rapids, Michigan
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1916000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
889000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
4552000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
841000 usd
CY2023Q4 us-gaap Other Short Term Investments
OtherShortTermInvestments
26301000 usd
CY2022Q4 us-gaap Other Short Term Investments
OtherShortTermInvestments
24839000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2396000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3010000 usd
CY2023Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
1660000 usd
CY2022Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
1527000 usd
CY2023Q4 us-gaap Reinsurance Recoverables Allowance
ReinsuranceRecoverablesAllowance
96000 usd
CY2022Q4 us-gaap Reinsurance Recoverables Allowance
ReinsuranceRecoverablesAllowance
0 usd
CY2023Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
21571000 usd
CY2022Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
9269000 usd
CY2023Q4 FGF Funds Deposited For Benefit Of Reinsured Companies
FundsDepositedForBenefitOfReinsuredCompanies
8002000 usd
CY2022Q4 FGF Funds Deposited For Benefit Of Reinsured Companies
FundsDepositedForBenefitOfReinsuredCompanies
9277000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
1254000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
712000 usd
CY2023Q4 us-gaap Assets
Assets
65736000 usd
CY2022Q4 us-gaap Assets
Assets
49475000 usd
CY2023Q4 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
9016000 usd
CY2022Q4 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
4409000 usd
CY2023Q4 us-gaap Unearned Premiums
UnearnedPremiums
13476000 usd
CY2022Q4 us-gaap Unearned Premiums
UnearnedPremiums
6823000 usd
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
206000 usd
CY2022Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
723000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
546000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
225000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
23244000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
12180000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
25.00
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
25.00
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
894580 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
894580 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
894580 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
894580 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
22365000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
22365000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10558931 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9410473 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10558931 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9410473 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
10000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
9000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
53264000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
50021000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33147000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-35100000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
42492000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37295000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
65736000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49475000 usd
CY2023 us-gaap Premiums Earned Net
PremiumsEarnedNet
16631000 usd
CY2022 us-gaap Premiums Earned Net
PremiumsEarnedNet
12998000 usd
CY2023 us-gaap Net Investment Income
NetInvestmentIncome
9798000 usd
CY2022 us-gaap Net Investment Income
NetInvestmentIncome
6777000 usd
CY2023 us-gaap Other Income
OtherIncome
413000 usd
CY2022 us-gaap Other Income
OtherIncome
320000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26842000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20095000 usd
CY2023 FGF Net Losses And Loss Adjustment Expenses
NetLossesAndLossAdjustmentExpenses
9713000 usd
CY2022 FGF Net Losses And Loss Adjustment Expenses
NetLossesAndLossAdjustmentExpenses
7484000 usd
CY2023 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
3623000 usd
CY2022 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
3169000 usd
CY2023 FGF General And Administrative Related Party Expense
GeneralAndAdministrativeRelatedPartyExpense
1825000 usd
CY2022 FGF General And Administrative Related Party Expense
GeneralAndAdministrativeRelatedPartyExpense
1825000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9661000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8354000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
22997000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
19007000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
3845000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
1088000 usd
CY2023 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1786000 usd
CY2022 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1789000 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2059000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-701000 usd
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.21
CY2023 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.21
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.09
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.09
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9991980 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9991980 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8030106 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8030106 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
34009000 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
255000 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3732000 usd
CY2022 us-gaap Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
2.00
CY2022 FGF Dividends Declared On Series A Preferred Shares
DividendsDeclaredOnSeriesAPreferredShares
-1789000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
1088000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
37295000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
37295000 usd
CY2023 FGF Cumulative Effect Of Adoption Of Accounting Guidance For Expected Credit Losses
CumulativeEffectOfAdoptionOfAccountingGuidanceForExpectedCreditLosses
-106000 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1964000 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1280000 usd
CY2023 us-gaap Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
2.00
CY2023 FGF Dividends Declared On Series A Preferred Shares
DividendsDeclaredOnSeriesAPreferredShares
-1786000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
3845000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
42492000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
42492000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
3845000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
1088000 usd
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
2684000 usd
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
13026000 usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3130000 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7618000 usd
CY2023 FGF Increase In Investment Without Readily Determinable Fair Value
IncreaseInInvestmentWithoutReadilyDeterminableFairValue
250000 usd
CY2023 FGF Increase In Fair Value Of Convertible Note
IncreaseInFairValueOfConvertibleNote
125000 usd
CY2023 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
3062000 usd
CY2022 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
-13797000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1964000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
255000 usd
CY2023 FGF Increase Decrease In Funds Deposited With Reinsured Companies
IncreaseDecreaseInFundsDepositedWithReinsuredCompanies
1275000 usd
CY2022 FGF Increase Decrease In Funds Deposited With Reinsured Companies
IncreaseDecreaseInFundsDepositedWithReinsuredCompanies
-4835000 usd
CY2023 us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
12408000 usd
CY2022 us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
5416000 usd
CY2023 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
133000 usd
CY2022 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
741000 usd
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
571000 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-114000 usd
CY2023 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
4607000 usd
CY2022 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
2276000 usd
CY2023 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
6653000 usd
CY2022 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
3213000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-196000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-129000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4215000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11022000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
81000 usd
CY2023 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
495000 usd
CY2022 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
8844000 usd
CY2023 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
950000 usd
CY2023 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
764000 usd
CY2022 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
4544000 usd
CY2023 us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
4604000 usd
CY2022 us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
698000 usd
CY2023 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
184000 usd
CY2022 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
230000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4107000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3453000 usd
CY2023 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1786000 usd
CY2022 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1789000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1280000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3732000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-506000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1943000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-614000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12532000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3010000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15542000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2396000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3010000 usd
CY2023 FGF Carrying Value Of Limited Liability Company Interests Received In Connection With Fg Special Situations Fund Unwind
CarryingValueOfLimitedLiabilityCompanyInterestsReceivedInConnectionWithFgSpecialSituationsFundUnwind
13754000 usd
CY2023 FGF Equity Securities In Oppfi Received In Connection With Fg Special Situations Fund Unwind
EquitySecuritiesInOppfiReceivedInConnectionWithFgSpecialSituationsFundUnwind
1916000 usd
CY2023 FGF Equity Securities In Icoreconnect Inc Received In Connection With Conversion Of Bridge Loan
EquitySecuritiesInIcoreconnectIncReceivedInConnectionWithConversionOfBridgeLoan
654000 usd
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_808_eus-gaap--NatureOfOperations_z5HDrQzULdX" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="fin6"></span>Note 1. <span id="xdx_825_zPGXULfXzmHf">Nature of Business</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fundamental Global Inc. (“FGF”, the “Company”, “we”, or “us”), formerly known as FG Financial Group, Inc., is a reinsurance, merchant banking and asset management holding company. We focus on opportunistic collateralized and loss capped reinsurance, while allocating capital to merchant banking activities. The Company’s principal business operations are conducted through its subsidiaries and affiliates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, FG Financial Holdings, LLC (“FG”), a private partnership focused on long-term strategic holdings, and its affiliated entity, collectively beneficially owned approximately <span id="xdx_90C_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20231231__srt--OwnershipAxis__custom--FGFinancialHoldingsLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmrYE96Fzy8l" title="Ownership percentage">54.6</span>% of our common stock. D. Kyle Cerminara, Chairman of our Board of Directors, serves as Chief Executive Officer, Co-Founder and Partner of FG.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reincorporation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective at 5:01 p.m. ET on December 9, 2022, the Company completed its reincorporation from a Delaware corporation to a Nevada corporation (the “Reincorporation”). The Reincorporation was accomplished by means of a merger by and between the Company and its former wholly owned subsidiary FG Financial Group, Inc., a Nevada corporation. As of December 9, 2022, the rights of the Company’s stockholders began to be governed by the Nevada corporation laws, our Amended and Restated Nevada Articles of Incorporation and our Nevada Bylaws. The Reincorporation was approved by the Company’s stockholders at a special meeting held on December 6, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other than the change in the state of incorporation, the Reincorporation did not result in any change in the business, physical location, management, assets, liabilities or net worth of the Company, nor did it result in any change in location of the Company’s employees, including the Company’s management.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Reincorporation did not alter any stockholder’s percentage ownership interest or number of shares owned in the Company and the Company’s common stock continues to be quoted on the Nasdaq Global Market under the same symbol “FGF” and the 8.00% Cumulative Preferred Stock, Series A of the Company continues to be quoted on the Nasdaq Global Market under the same symbol, “FGFPP.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Current Business</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our strategy has evolved to focus on opportunistic collateralized and loss capped reinsurance, with capital allocation to merchant banking activities with asymmetrical risk/reward opportunities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, the business operates as a diversified holding company of insurance, reinsurance, asset management, our Special purpose acquisition corporation “SPAC” Platform businesses, and our merchant banking division.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Insurance</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsor Protection Coverage and Risk, Inc. has been formed as a special purpose captive in South Carolina to provide reinsurance coverage for Sides A, B, &amp; C Directors and Officers Liability insurance coverage for related and unrelated entities of FG Reinsurance Ltd. (“FGRe”). These will include SPAC entities engaged in the services or business of taking companies public, as well as small cap businesses performing an initial public offering. Sponsor Protection Coverage and Risk, Inc. has yet to write any business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Reinsurance</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s wholly owned reinsurance subsidiary, FGRe, a Cayman Islands limited liability company, provides specialty property and casualty reinsurance. FGRe has been granted a Class B (iii) insurer license in accordance with the terms of The Insurance Act (as revised) of the Cayman Islands and underlying regulations thereto and is subject to regulation by the Cayman Islands Monetary Authority (the “Authority”). The terms of the license require advance approval from the Authority should FGRe wish to enter into any reinsurance agreements which are not fully collateralized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, the Company had <span id="xdx_901_ecustom--NumberOfActiveReinsuranceContracts_iI_dc_uInteger_c20231231_zQwJ2JYLQNb2" title="Number of active reinsurance contracts">eight</span> active reinsurance contracts, including participating in a Funds at Lloyds (“FAL”) syndicate covering risks written by the syndicate during the 2021, 2022 and 2023 calendar years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, during 2023, the Company began to focus on growing fee-based revenue through FG Re Solutions, Ltd.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Asset Management</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FG Strategic Consulting, LLC, (“FGSC”) a wholly-owned subsidiary of the Company, provides investment advisory services, including identifying, analyzing and recommending potential investments, advising as to existing investments and investment optimization, recommending investment dispositions, and providing advice regarding macro-economic conditions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>SPAC Platform and Merchant Banking</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 21, 2020, we formed FG Management Solutions LLC (“FGMS”), formerly known as FG SPAC Solutions, LLC, a Delaware company, to facilitate the launch of our “SPAC Platform.” Under the SPAC Platform, we provide various strategic, administrative, and regulatory support services to newly formed SPACs for a monthly fee. Additionally, the Company co-founded a partnership, FG Merchant Partners, LP (“FGMP”), formerly known as FG SPAC Partners, LP, to participate as a co-sponsor for newly formed SPACs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the third quarter of 2022, the Company announced the expansion of its growth strategy through the formation of a merchant banking division.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the fourth quarter of 2022, the Company invested $<span id="xdx_906_eus-gaap--Investments_iI_pn5n6_c20221231__dei--LegalEntityAxis__custom--FGCommunitiesIncMember_zpxHPAV8Day5" title="Investments">2.0</span> million into its first merchant banking project, FG Communities, Inc. (“FGC”). FGC is a self-managed real estate company focused on a growing portfolio of manufactured housing communities which are owned and operated by FGC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 FGF Number Of Active Reinsurance Contracts
NumberOfActiveReinsuranceContracts
8 integer
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84D_eus-gaap--UseOfEstimates_zTigH7xDZ5ke" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_z0ffEhw4IEwe">The Use of Estimates in the Preparation of Consolidated Financial Statements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the application of policies and the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses for the reporting period. Actual results could differ from these estimates. Estimates and their underlying assumptions are reviewed on an ongoing basis. Changes in estimates are recorded in the accounting period in which they are determined. The significant estimates in the accompanying consolidated financial statements include the valuation of our other investments, the valuation of net deferred income taxes, premium revenue recognition, and reserves for loss and loss adjustment expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.20 pure
CY2023Q4 us-gaap Cash
Cash
200000 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zegjv5KHqubi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zpgebZOKxlga">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments which potentially expose the Company to concentrations of credit risk include investments, cash, and deposits with reinsured companies. The Company maintains its cash with a major U.S. domestic banking institution which is insured by the Federal Deposit Insurance Corporation (“FDIC”) for up to $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_c20231231_z52S1kds0Nkk" title="Cash FDIC insured amount">250,000</span>. As of December 31, 2023, the Company held funds in excess of these FDIC insured amounts. The terms of these deposits are on demand to mitigate some of the associated risk. The Company has not incurred losses related to these deposits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q1 us-gaap Cumulative Earnings Deficit
CumulativeEarningsDeficit
100000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
100000 usd
CY2023Q4 us-gaap Investments
Investments
450000 usd
CY2023Q4 us-gaap Securities Purchased Under Agreements To Resell Amount Offset Against Collateral
SecuritiesPurchasedUnderAgreementsToResellAmountOffsetAgainstCollateral
8000000.0 usd
CY2022Q4 us-gaap Securities Purchased Under Agreements To Resell Amount Offset Against Collateral
SecuritiesPurchasedUnderAgreementsToResellAmountOffsetAgainstCollateral
9300000 usd
CY2023Q1 us-gaap Cumulative Earnings Deficit
CumulativeEarningsDeficit
100000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
1916000 usd
CY2023 us-gaap Debt Securities Trading Unrealized Gain
DebtSecuritiesTradingUnrealizedGain
2636000 usd
CY2023Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
4552000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
889000 usd
CY2022 us-gaap Debt Securities Trading Unrealized Loss
DebtSecuritiesTradingUnrealizedLoss
48000 usd
CY2022Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
841000 usd
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
16000 shares
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
23532000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
22586000 usd
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
2319000 usd
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
2253000 usd
CY2023Q4 us-gaap Other Notes Payable
OtherNotesPayable
450000 usd
CY2023Q4 us-gaap Other Short Term Investments
OtherShortTermInvestments
26301000 usd
CY2022Q4 us-gaap Other Short Term Investments
OtherShortTermInvestments
24839000 usd
CY2023 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
300000 usd
CY2022 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
0 usd
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
2253000 usd
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
483000 usd
CY2022 FGF Contributions In Investments Without Readily Determinable Fair Value
ContributionsInInvestmentsWithoutReadilyDeterminableFairValue
2000000 usd
CY2023 FGF Distributions From Investments Without Readily Determinable Fair Value
DistributionsFromInvestmentsWithoutReadilyDeterminableFairValue
184000 usd
CY2022 FGF Distributions From Investments Without Readily Determinable Fair Value
DistributionsFromInvestmentsWithoutReadilyDeterminableFairValue
230000 usd
CY2023 FGF Increase Due To Change In Observable Price
IncreaseDueToChangeInObservablePrice
250000 usd
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
2319000 usd
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
2253000 usd
CY2023 us-gaap Net Investment Income
NetInvestmentIncome
9798000 usd
CY2022 us-gaap Net Investment Income
NetInvestmentIncome
6777000 usd
CY2021Q4 us-gaap Reinsurance Recoverable For Unpaid Claims And Claims Adjustments
ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
4338000 usd
CY2022Q4 us-gaap Reinsurance Recoverable For Unpaid Claims And Claims Adjustments
ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
7484000 usd
CY2023Q4 us-gaap Reinsurance Recoverable For Unpaid Claims And Claims Adjustments
ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
9713000 usd
CY2023Q4 us-gaap Reinsurance Receivables Incurred But Not Reported Claims
ReinsuranceReceivablesIncurredButNotReportedClaims
6270000 usd
CY2021Q4 us-gaap Reinsurance Recoverables On Paid Losses
ReinsuranceRecoverablesOnPaidLosses
2205000 usd
CY2022Q4 us-gaap Reinsurance Recoverables On Paid Losses
ReinsuranceRecoverablesOnPaidLosses
5208000 usd
CY2023Q4 us-gaap Reinsurance Recoverables On Paid Losses
ReinsuranceRecoverablesOnPaidLosses
5106000 usd
CY2023Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Reported Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount
9016000 usd
CY2022Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Reported Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount
4409000 usd
CY2023Q4 us-gaap Reinsurance Recoverables On Paid And Unpaid Losses
ReinsuranceRecoverablesOnPaidAndUnpaidLosses
9016000 usd
CY2022Q4 us-gaap Reinsurance Recoverables On Paid And Unpaid Losses
ReinsuranceRecoverablesOnPaidAndUnpaidLosses
4409000 usd
CY2023 us-gaap Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense
ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
<p id="xdx_896_eus-gaap--ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_zd9EbtvtriW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of changes in outstanding loss and loss adjustment expense reserves for the years ended December 31, 2023 and 2022 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BE_zkpgWR4H1Szd" style="display: none">Schedule of Changes in Outstanding Loss Adjustment Expense Reserves</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td>(in thousands)</td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20230101__20231231_zhxCHxqvcnb3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31, 2023</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" id="xdx_49A_20220101__20221231_z6j1AabEZ8Me" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td> </td></tr> <tr id="xdx_407_eus-gaap--ReinsuranceRecoverables_iS_pn3n3_zLRGz460aZp6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Balance, January 1</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">4,409</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,133</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Incurred related to:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ReinsuranceLossOnUncollectibleAccountsInPeriodAmount_pn3n3_zz8YWUK7XsD9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current year</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,487</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,628</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--ReinsuranceLossOnUncollectibleAccountsInPriorPeriodAmount_pn3n3_zNxtveuD7I78" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prior years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,226</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">856</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Paid related to:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--ReinsuranceRecoverableCreditLossExpenseReversal_pn3n3_zhN0MIQk0ffh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Current year</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,803</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,822</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_ecustom--ReinsuranceRecoverableCreditLossExpenseReversalPriorYear_pn3n3_zEFUGa6NZoOc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Prior years</td><td style="font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-style: normal; font-weight: normal">(1,303</span></td><td style="font-weight: bold; text-align: left"><span style="font-style: normal; font-weight: normal">)</span></td><td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,386</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--ReinsuranceRecoverables_iE_pn3n3" style="vertical-align: bottom; background-color: White"> <td>Balance, December 31</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9,016</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4,409</td><td style="text-align: left"> </td></tr> </table>
CY2022Q4 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
4409000 usd
CY2021Q4 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
2133000 usd
CY2023 us-gaap Reinsurance Loss On Uncollectible Accounts In Period Amount
ReinsuranceLossOnUncollectibleAccountsInPeriodAmount
8487000 usd
CY2022 us-gaap Reinsurance Loss On Uncollectible Accounts In Period Amount
ReinsuranceLossOnUncollectibleAccountsInPeriodAmount
6628000 usd
CY2023 FGF Reinsurance Loss On Uncollectible Accounts In Prior Period Amount
ReinsuranceLossOnUncollectibleAccountsInPriorPeriodAmount
1226000 usd
CY2022 FGF Reinsurance Loss On Uncollectible Accounts In Prior Period Amount
ReinsuranceLossOnUncollectibleAccountsInPriorPeriodAmount
856000 usd
CY2023 us-gaap Reinsurance Recoverable Credit Loss Expense Reversal
ReinsuranceRecoverableCreditLossExpenseReversal
-3803000 usd
CY2022 us-gaap Reinsurance Recoverable Credit Loss Expense Reversal
ReinsuranceRecoverableCreditLossExpenseReversal
-3822000 usd
CY2023 FGF Reinsurance Recoverable Credit Loss Expense Reversal Prior Year
ReinsuranceRecoverableCreditLossExpenseReversalPriorYear
-1303000 usd
CY2022 FGF Reinsurance Recoverable Credit Loss Expense Reversal Prior Year
ReinsuranceRecoverableCreditLossExpenseReversalPriorYear
-1386000 usd
CY2023Q4 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
9016000 usd
CY2022Q4 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
4409000 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
807000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
229000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-832000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.217 pure
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-252000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.231 pure
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
25000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.007 pure
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
23000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.021 pure
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8500000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3800000 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
4700000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
5117000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4171000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves
70000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves
39000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve
566000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve
287000 usd
CY2023Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
2377000 usd
CY2022Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
4313000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
294000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
242000 usd
CY2023Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
1000 usd
CY2022Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
5000 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
30000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
9000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8455000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
9066000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4654000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5463000 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3801000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3603000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
3453000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
3282000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost
DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost
348000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost
DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost
321000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3801000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3603000 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
24400000 usd
CY2023Q1 FGF Employee Stock Purchase Plan Addition Description
EmployeeStockPurchasePlanAdditionDescription
the board of directors approved an employee purchase plan (“ESPP Plan”) whereby qualifying employees can choose each year to have up to 5% of their annual base earnings withheld to purchase the Company’s common shares in the open market. The Company matches 100% of the employee’s contribution amount after twelve months of employment
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4560 pure
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0115 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2023 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2000000.0 usd
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
255000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1300000 usd
CY2023Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
865000 shares
CY2023Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.85
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1300000 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10558931 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9410473 shares
CY2023 us-gaap Description Of Regulatory Capital Requirements Under Insurance Regulations
DescriptionOfRegulatoryCapitalRequirementsUnderInsuranceRegulations
In accordance with the terms of The Insurance Regulations, as a Class B(iii)insurer under the Act, the Company is required to maintain a minimum capital of $200,000 and a prescribed capital of $1,622,324 in line with the Regulations based on 15% of the first $5 million in net earned premium and 7.5% of additional net earned premium up to $20,000,000. The Company was in compliance with these requirements as of December 31, 2023
CY2023 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
3845000 usd
CY2022 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1088000 usd
CY2023 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1786000 usd
CY2022 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1789000 usd
CY2023 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
2059000 usd
CY2022 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-701000 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9991980 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8030106 shares
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.21
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.09
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1176108 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
411382 shares
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1 pure
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.03 pure
CY2023 FGF Percentage Of Additional Contribution Matched By Employer
PercentageOfAdditionalContributionMatchedByEmployer
0.50 pure
CY2023 FGF Additional Limited Contributions By Employees Employer Match
AdditionalLimitedContributionsByEmployeesEmployerMatch
0.02 pure
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
26000 usd
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
44000 usd
CY2023Q1 FGF Employee Stock Purchase Plan Description
EmployeeStockPurchasePlanDescription
the board of directors approved an employee purchase plan (“ESPP Plan”) whereby qualifying employees can choose each year to have up to 5% of their annual base earnings withheld to purchase the Company’s common shares in the open market. The Company matches 100% of the employee’s contribution amount after thirty days of employment
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2022Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.08 pure
CY2023Q4 FGF Operating Asset And Lease Liability
OperatingAssetAndLeaseLiability
39000 usd
CY2022Q4 FGF Operating Asset And Lease Liability
OperatingAssetAndLeaseLiability
56000 usd
CY2023 us-gaap Payments For Rent
PaymentsForRent
15000 usd
CY2022 us-gaap Payments For Rent
PaymentsForRent
17000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
21000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
21000 usd
CY2023Q4 FGF Lessee Operating Lease Liability Imputed Interest Net Amount
LesseeOperatingLeaseLiabilityImputedInterestNetAmount
3000 usd
CY2023Q4 FGF Operating Asset And Lease Liability
OperatingAssetAndLeaseLiability
39000 usd
CY2023 us-gaap Premiums Earned Net
PremiumsEarnedNet
16631000 usd
CY2023 us-gaap Net Investment Income
NetInvestmentIncome
9798000 usd
CY2023 us-gaap Other Income
OtherIncome
413000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26842000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3845000 usd
CY2023Q4 us-gaap Assets
Assets
65736000 usd
CY2022 us-gaap Premiums Earned Net
PremiumsEarnedNet
12998000 usd
CY2022 us-gaap Net Investment Income
NetInvestmentIncome
6777000 usd
CY2022 us-gaap Other Income
OtherIncome
320000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20095000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1088000 usd
CY2022Q4 us-gaap Assets
Assets
49475000 usd

Files In Submission

Name View Source Status
0001493152-24-009954-index-headers.html Edgar Link pending
0001493152-24-009954-index.html Edgar Link pending
0001493152-24-009954.txt Edgar Link pending
0001493152-24-009954-xbrl.zip Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex97.htm Edgar Link pending
fgf-20231231.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
fgf-20231231_def.xml Edgar Link unprocessable
fgf-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
fgf-20231231_cal.xml Edgar Link unprocessable
fgf-20231231_lab.xml Edgar Link unprocessable